Previous studies ( 1 ) have shown that the specific alpha-ketolic steroid metabolites found in the urine after administration of a known alphaketolic steroid reflect, to a limited extent, the nature of the precursor. With this study as a baseline, we have determined the major urinary alphaketolic steroid metabolites found after intravenous infusion of human subjects with ACTH, and some of those found in the urine of a man with Cushing's syndrome, and in that of a woman with metastatic adrenocortical carcinoma. The results of this study and some speculations concerning the possible nature and rate of alpha-ketolic steroid secretion are presented in this paper.
Previous studies ( 1 ) have shown that the specific alpha-ketolic steroid metabolites found in the urine after administration of a known alphaketolic steroid reflect, to a limited extent, the nature of the precursor. With this study as a baseline, we have determined the major urinary alphaketolic steroid metabolites found after intravenous infusion of human subjects with ACTH, and some of those found in the urine of a man with Cushing's syndrome, and in that of a woman with metastatic adrenocortical carcinoma. The results of this study and some speculations concerning the possible nature and rate of alpha-ketolic steroid secretion are presented in this paper.
METHODS
Methods employed and their limitations have been presented previously (1) . Terminology has been previously discussed (1) . The abbreviations employed are indicated in Table I . The commonly employed letter designations (Kendall's compounds F, E, B, and A; Reichstein's S and DOC) have been used with the addition that HI indicates the tetrahydro compound (Pregnane-3a-ol) and H, indicates the "dihydro compound" (Pregnane-3-one). Glucuronidase, 100 units per ml. of urine, was employed for hydrolysis. (It is now recognized that this is insufficient for maximum hydrolysis and hence for maximum yield.) After glucuronidase hydrolysis, the urine was extracted at pH 1 with CHC1, for one hour on an oscillating shaker. Paper chromatographic separation was accomplished primarily by using the toluene-propylene glycol system of Burton, Zaffaroni, and Keutmann (2) . After development of the chromatogram, the absorption of ultra-violet light of the paper strip at 245 mn was determined directly in a Beckman DU spectrophotometer ' This investigation was supported in part by research grant H-922 from the National Heart Institute, of the Heard, Sobel, and Venning (4) after acid hydrolysis (Ac. R-L) and after glucuronidase followed by acid hydrolysis (G'ase R-L) as previously described (1) . The total neutral 17-ketosteroids (17-KS) were determined by a modification of the method of Holtorff and Koch (5) .
RESULTS
Part I. Effects of ACTH 1. Identification studies. Figure 1 shows the effects upon urinary alpha-ketolic steroid excretion of ACTH administered intravenously to four human subjects. The identified peaks are indicated by diagonal lines. The identification procedures are listed in Table I , and semi-quantitative estimations of the "24-hour excretion" of the identified and some only partially identified alphaketolic metabolites in Table II . In the most polar fraction (X), the peaks in the H4F and H4E positions are apparent in all four individuals. These 
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have been identified in the case of subjects HI., ME., and MUR. after ACTH. It is evident from this and previous studies (1) as well as the position and relatively small absorption at 245 m,u (not shown) in these regions that the twin alphaketolic peaks in the first portion of fraction X in the other subjects are probably formed by H4F and H4E. The increased excretion of hydrocortisone (F) after administration of ACTH is also indicated.
Two or more alpha-ketolic steroids are frequently found at the cortisone (E) position as shown by rechromatography. In HI. approximately 20 per cent of this peak is possibly the tetrahydro form of Reichstein's compound S, i.e., H4S. However, the possibility exists that the substance may be the A9-11 unsaturated compound which might arise as a dehydration product of H4F. This is considered possible since the dehydration product of 11,8-hydroxyandrosterone (A9-11 androstenolone) has been found by Lieberman, Mond, and Smyles (6) after chromatography of urine extracts on alumina. In this instance, extractions were made for 48 hours by the continuous ether method at pH 5, after glucuronidase hydrolysis. The extraction method used by us exposed the urinary steroids to pH 1 for one hour. Since not enough material was available to permit infrared spectrometry and the A9-11 compound has not been available for testing the running rates and the absorption spectrum in sulfuric acid, this possibility cannot be definitely excluded. However, it seems possible that this is, in fact, H4S since the compound has the same characteristics as material identified by infrared spectrometry in extracts of urine from a subject with Cushing's syndrome (MUS.) and from a subject with adrenal cortical carcinoma (CA.) as H4S. In addition to the data shown in Table I , it has been found that the mobility in the benzene-formamide system of the unknown approximates that of an authentic sample of H4S (See Addendum).
In the mid-polar fraction (Y), peak 1 of subjects HI. and ME. has been identified as tetrahydro B, (H4B) (7) and peak 3 of fraction Y of subject ME. as tetrahydro A, (H4A) (7) . In addition, the Y2 peak of subject ME. has been identified as the allo form of tetrahydro B, (allo-H4B) (7) . Corticosterone (B) has been demonstrated in the urine of the two normal subjects after ACTH (7). The presence of compound A (11-dehydrocorticosterone) was indicated (see Table  I ) but this compound was not definitely identified (See Addendum).
2. Chromatographic pattern. The chromatographic pattern (Figure 1 ) must be considered in relation to the effects of variations in technics as well as the proportion of the 24-hour extract employed. However, it is apparent that there is a general similarity of appearance in the chromatograms of extracts of the urine of all four individuals after ACTH. There is also a general similarity in the pre-ACTH patterns. The significance of the increased excretion of "E position" steroids in patient MU. before ACTH is unknown. The alpha-ketolic metabolites in the positions of H4F, H4E, and of compounds F and E, as well as those in the Y and Z chromatographic fractions, are considerably increased by ACTH.
3. Effect of ACTH on urinary excretion of steroids measured by group reactions. The total AKSM (alpha-ketolic steroid metabolites) are increased after ACTH as indicated in Figure 1 . The increase in AKSM is relatively greater than in the G'ase R-L (Reducing lipids extractable after glucuronidase plus acid hydrolysis) and considerably so compared to the relative increase of Acid R-L (Reducing lipids after acid hydrolysis only) and the total neutral 17-ketosteroids (17-KS) tabulated on the right-hand side of Figure 1 . These findings are similar to those shown in Table III of the previous paper (1) after the administration of the "six physiologically active" alpha-ketolic steroids. Figure 2 shows the distribution of the AKSM by fractions. It includes data from chromatographic analysis of urine from normal individuals not shown in Figure 1 . ACTH infusion for eight hours on one day increased the AKSM in all three fractions, but the largest relative increase with blue tetrazolium. The density of the blue color produced by reaction with alpha-ketolic steroids was then read (by means of an adaptor) directly from the paper in a Beckman DU spectrophotometer at 600 m/A. The density is charted in relation to the distance from the "starting line" as the abscissa of the horizontal "channels." More than one compound may be in the same region, so that further studies were necessary for isolation. The most polar (X), "mid-polar" (Y), and least polar (Z) fractions are charted. The percentage figures in each fraction indicate the proportion of the 24-hour urine represented by the amount of extract used tration of F or E (1, (8) (9) (10) (11) and the last four are those found in large amounts after administration of compounds B or A (1, 12) . Cortisone (E), although indicated (Table I) , was not positively identified after administration of ACTH but has been positively identified by others (Table III) .
In addition, the presence of A and of H,S is suggested by the evidence presented in Table I . Table III lists the 11 alpha-ketolic steroids that have been positively identified to date in the urine of humans without known adrenocortical disease.
Apparently, A5-pregnene-3,8, 21-diol-20-one (13) has not been demonstrated to be a metabolite of these precursors. Aldosterone, present in minute amounts, has been identified in extracts of urine prepared by Luetscher, Wettstein, and Neher (14) .
It thus seems probable that the alpha-ketolic steroids secreted by the adrenal cortex in the largest quantities are compounds F (or E) and B (or A) and possibly smaller amounts of compound S. The hydroxyl and keto groups at carbon atom 11 are interconvertible for compounds F and E (1, 8-11) and for compounds B and A (1), so the major alpha-ketolic metabolites produced by administration of F and E are similar; as are those for B and A. Therefore, the exact precursor of the metabolites of these pairs is difficult to determine.
In an attempt to obtain further data bearing on the precursors of the urinary alpha-ketolic metabolites, the amounts of identified and partially identified metabolites found after administration of ACTH and in pathologic adrenocortical hyperfunction have been estimated (Table II) . The ratio of the estimated quantities of the various metabolites have been examined and compared to the ratios found after oral administration of F or E and B or A in the previously reported experiments (1) . It is recognized that dosage and route of administration may influence the absolute values and the ratios. These limited comparisons, however, do not afford clear-cut evidence indicating that the secretion of F is greater than E; nor that of B is greater than A.
Evidences from the isolation studies by Romanoff, Hudson, and Pincus (15) of blood from the adrenal vein of a man with prostatic carcinoma would suggest that compound F and compound B are secreted in far greater amounts than the other active alpha-ketolic steroids. In addition, studies of peripheral blood, although of lesser value in determining specific steroid secretion by the adrenal cortex, indicate that F and B are present in greater quantity than E or A. Thus, Morris and Williams (16) using micro-polarographic technics have presented evidence indicating the concentration of F and B in peripheral blood to be about twice that of E and A, while Bush and Sandberg (17) find evidence only for F and B.
The factors affecting the rate and type of adrenocortical secretion, in particular the species variation, has recently been reviewed by Bush (18) . The values reported by Hechter (19) using perfused bovine adrenals would suggest that F and B were the chief alpha-ketolic steroids at least in that species. The extensive studies of Pincus, Romanoff, and Romanoff (20) Only those compounds in which the studies included one or both of these technics are considered to be identified. The abbreviations (see Table I ) above the diagonally-lined peaks indicate the identity of the steroid. The numbers on the peaks may be used in referring to the identification studies listed in Table I (Table IV) . These speculations are based on calculations derived from previous experiments in which the urinary alpha-ketolic steroid metabolites were measured following the oral administration of these steroids to individuals with adrenal cortical insufficiency (1) . The proportion of orally administered alpha-ketolic steroid metabolites appearing in the urine as alpha-ketolic metabolic products was calculated from these data. (23, 24) ; (c) the ratio of calculated F to B secretion in normal individuals, and the ratio for those given ACTH for one day, are similar to those reported by Bush and Sandberg (17) . In their study of peripheral blood of individuals given ACTH, the ratio of F to a compound tentatively identified as B was > 4 and for untreated individuals was > 5. However, the calculated ratio is somewhat less than the F to B ratio of 11 for material isolated from adrenal vein blood by Romanoff, Hudson, and Pincus (15) (25) of an increasing ratio of F to B in the peripheral blood of rabbits which were injected with ACTH up to periods of four weeks. In addition, Bush (26) has found a plasma F to "B" ratio of 20 to 1 in adrenal vein blood of a patient with Cushing's syndrome; a figure that compares quite well with the calculated production ratios of these compounds in our three patients with Cushing's syndrome.
Considerations concerning allopregnane derivatives. Engel, Carter, and Springer (12) have presented evidence that allo-H4B (allopregnane-3a, 11, 21-triol-20-one) is one of the major alphaketolic metabolites of compound B, and we have Table I and text.)
The identification procedures for those substances, the values for which are not enclosed in parentheses, included spectrometry in H2S04 or infrared spectrometry or both as well as other studies listed in Table I . (1) . The finding of allo-H4B after ACTH, (7) is probably best explained on the basis of metabolic reduction of compound B rather than direct production of allo-H4B by the cortex. This seems probable since allopregnane-3a, 11/3, 21-triol-20-one has not been identified in adrenal extracts although the 3,8 isomer has been isolated in relatively small amounts and all the ring A saturated alpha-ketols so far identified have had the allo configuration (13 There was rounding of the face which was a dusky, brown-red color, multiple "bruises," no purple striae, moderate hirsutism, blood pressure of 170/110 mm. Hg, a glucose tolerance curve as follows: fasting-85, onehalf hour-180, one hour-184, two hours-162, and three hours-91 mg. per 100 ml. of blood, increased 17-ketosteroids and corticoid excretion (after acid hydrolysis), and loss of menses at age 41. There was no x-ray evidence of adrenal cortical tumor. No therapy had been given prior to the collection of urine for chromatography.
Identification studies and chromatographic pat- tern (Cushing's syndrome) Table I and Figure 3 show that H4F, H4E, E, and H4S were identified in extracts of the urine of MUS., the male subject with florid Cushing's syndrome. In addition, large amounts of F were indicated, as partially identified by RDOC, ultraviolet light absorption, positive Porter-Silber test and fluorescence in sulfuric acid. Table II gives the approximate amounts of the identified and partially identified compounds. Figure 3 demonstrates the chromatographic patterns in subjects with hyperfunction of the adrenal cortical tissue, i.e., three patients with Cushing's syndrome (without adrenocortical tumor) and a patient with functioning metastases from adrenal cortical carcinoma. The general similarity of the chromatographic patterns of the individuals with Cushing's syndrome to those of the patients receiving ACTH is apparent, particularly that of subject MUR. who received ACTH for three days (compare Figures 1 and 3) . The peak at the F position was present in all three patients with Cushing's syndrome as were the peaks in the H,F and H4E positions. In addition, there were relatively large amounts of AKSM present at the E position in all three individuals with Cushing's syndrome using a proportion of the 24-hour urine specimen which usually failed to show an alpha-ketolic peak at this position with urine extract from "normal" individuals. However, some of this peak in subjects FR. and ST.
may be due to the presence of H4S, since in sub- Figure 1 , for explanation of charting technic and Table I for identification studies. The similarity of pattern (particularly the presence of the relatively large peak at the F position in all three patients with Cushing's syndrome) to the chromatograms of normal and hypertensive subjects after ACTH (see Figure 1) should be noted.
Some of the fractions used in these studies were developed on slightly longer strips for a longer period while others were developed over a shorter period than usual. Therefore, there is a wider range of position of known metabolites as indicated by the lengths of the bars at the bottom of the chart. ject MUS. approximately 60 per cent of this double peak (X4 and X6) was due to H,S.
Comment
Identified alpha-ketolic steroid metabolites.
The identification of H,F, H4E, E, and H4S in the urine of a subject with Cushing's syndrome (MUS.) is in accord with the finding of the first three steroids in the urine of normal subjects with or without administration of ACTH (Table III) .
Mason and Sprague (27) first identified hydrocortisone in the urine of a subject with Cushing's syndrome. Others have also reported its presence (28, 29) as well as H4F (29) , HE (28) (29) (30) and cortisone (28, 29) in the urine of subjects with this condition. Bush (26) (Figure 2) as measured by the areas underneath the curves is greater in the case of subject MUS. than that found after the infusion of ACTH ( Figure 1) ; and greater in the other two subjects with Cushing's syndrome than that found in normal individuals not given ACTH. However, the proportion of alpha-ketols present ( Figure 2 and (25) . They demonstrated an increase of compound F and a progressive decrease in compound B in the adrenal vein blood of rabbits measured at the 7th, and the 21st to 28th day of ACTH injection. These considerations suggest that the higher proportion of steroid metabolites in the most polar fraction (X) in the chromatograms of urinary extracts from patients with Cushing's syndrome, found by ourselves and Wilson, Fairbanks, and Scialabba (29) is due to an increase in the secretion ratio of F and/or E to B and/or A (see Table IV ). They also suggest that this change is presumably due to prolonged stimulation by greater than usual amounts of ACTH. However, measurements of blood levels of ACTH in this condition have given widely varying results (31), although recently Rubin, Dorfman, and Dorfman (32) has reported a significant increase of ACTH excretion in the urine of an individual with Cushing's syndrome.
There was an absolute increase in excretion of fractions Y and Z (indicating an increase in the metabolic products of B or A) in the subject MUS. with florid Cushing's syndrome, but this was not found in subjects FR. or ST. in whom the manifestations were less marked. Speculations from these findings concerning probable secretion rates of the adrenal cortex in Cushing's syndrome are presented in the Comments, Part I, and in Table IV. Adrenal cortical carcinoma-Case history Subject CA. This case has previously been reported in detail (33) . The finding in her urine of pregnane-3a, 17a, 21-triol-20-one (H.S -"tetrahydro compound S") has also been previously reported (34) Chromatographic pattern and identification studies (adrenal cortical carcinoma) The alpha-ketolic peak produced by tetrahydro compound S in the X fraction of the chromatogram is shown in Figure 3 and identification studies listed in Table I . A semi-quantitative estimate (Table II) indicates that approximately 12.4 mg. of tetrahydro compound S were extractable (by the method used) from the 24-hour urine collection. In addition, a small amount of material with many of the characteristics of compound S was isolated (see Tables I and II) . The identification procedures listed in Table I for the suspected compound S do not include spectrometry in sulfuric acid or infrared spectrometry since insufficient material was obtained from the aliquot of the 24-hour urine specimen employed. However, the development of a red color in sulfuric acid (36) in association with running rates (RDOC), absorption of ultraviolet light and positive Porter-Silber reaction all indicate that the substance may be Reichstein's compound S.
As previously reported (1), the administration of 100 mg. of S acetate on three occasions to two subjects with markedly decreased adrenocortical function resulted in an average urinary excretion of 2.1 mg. of AKSM per 24 hrs.; over 90 per cent of this was H4S. Although the amount of alphaketols excreted is apparently not a straight-line function of the dose administered, calculations from the above suggest that this patient was excreting metabolites equivalent to that resulting from oral ingestion of approximately 600 mg. of compound S per day. Since (a) the production of compounds F (and/or E) appeared to be within normal limits in the subject CA. as judged by the excretion of H4F and H4E in "normal" amounts, and (b) at post-mortem the remaining adrenal was normal histologically and not atrophic (wt. = 7 gm.), it would appear likely that this remaining adrenal might have accounted for the hypothesized normal rate of production of F (and/ or E).
The production of ACTH was apparently not significantly inhibited, since the remaining adrenal was not atrophic. This is in agreement with the previously demonstrated weak ACTH suppressing effect of compound S in the rat (37) . It would also seem probable that the major alpha-ketolic steroid produced by the metastatic adrenal carcinoma was compound S. Hechter (19) has postulated the production of compound S as an intermediate in the production of F from 17-hydroxyprogesterone (19 (33) in the urine cannot be explained on this basis alone (22) . In addition, the chromatographic evidence of "normal" amounts of H4F and H4E would seem to indicate a relatively normal amount of F and/or E secretion; so, apparently, the hypoglycemia was not due to an absolute insufficiency of F (or E), unless there was a considerable decrease in secretion from time to time.
DISCUSSION
Three previously identified and four "new" alpha-ketolic steroid metabolites have been identified in the urine of subjects given intravenous ACTH and four metabolites in a subject with Cushing's syndrome and three in a subject with adrenocortical carcinoma. Comments after Parts I and II present certain speculations concerning the probable precursors of these alpha-ketolic metabolites. Table III lists a total of 11 alpha-ketols that have been identified in the urine of individuals without adrenocortical disease. However, it is emphasized that many more as yet unidentified alpha-ketols are present in lesser amounts, as indicated by the studies of Romanoff, Wolf, Constandse, and Pincus (38) . 2. The first three compounds have previously been identified as metabolites of F and E, and the last four as metabolites of B and A. Since B and A, as well as F and E, are interconvertible, even in individuals with severely impaired adrenal function, deductions from peripheral blood or urine studies concerning the specific adrenal cor-tical precursor of the respective metabolites of these two pairs are difficult. Some of the evidence concerning adrenocortical secretion has been presented. It suggests that F and B are probably secreted in greater quantities than other compounds.
3. The finding of allo-H4B as a urinary metabolite after ACTH infusion has been discussed in the light of recent evidence indicating this to be one of the major metabolites of compound B.
4. Pregnane-3a, 17a, 21-triol-20-one (H4S) has been found in the urine of a man with Cushing's syndrome and in large amounts in the urine of a woman with metastatic adrenocortical carcinoma. The implications are discussed.
5. The similarity of the chromatographic pattern of the alpha-ketolic steroid metabolites found in urine extracts of individuals with Cushing's syndrome to that found after three days of ACTH infusion is presented. The difference in chromatographic pattern between these subjects and those individuals given ACTH for only one day is noted, and implications concerning a possible change in secretion with prolonged stimulation by ACTH discussed.
6. The semi-quantitative values obtained for specific, identified, and partially identified alphaketolic metabolites, as well as estimations (by group reaction technics) of the total alpha-ketolic steroid metabolites (AKSM), reducing lipids (corticoids) after acid hydrolysis (Acid R-L) and after glucuronidase plus acid hydrolysis (G'ase R-L) and the 17-ketosteroids in normal individuals, individuals after ACTH and patients with Cushing's syndrome and adrenocortical carcinoma are presented. Addendum I-LS (Pregnane-3a, 17a, 21-triol-20-one), B (A'-Pregnene-ll,B, 21-diol-3, 20-dione) and A (A4-Pregnene-21-ol-3, 11, 20-trione) have recently been identified (infrared spectrometry and spectrometry in H,SO and other tests) in extracts of the urine of a man receiving ACTH during an episode of rheumatic fever. This lends further support to the supposition that peak X, of subject HI. receiving ACTH and Z. of HI. and ME. combined (see Table I ) are in fact HIS and A, respectively.
